Dashboard
Manage Tickers

AZNASTRAZENECA PLC

Nasdaq astrazeneca.com


$ 75.77 $ -0.59 (-0.77 %)    

Monday, 06-May-2024 15:59:59 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 439.97 $ 4.77 (1.1 %)
DIA $ 388.40 $ 1.68 (0.43 %)
SPY $ 516.34 $ 5.28 (1.03 %)
TLT $ 90.16 $ 0.35 (0.39 %)
GLD $ 215.21 $ 2.24 (1.05 %)
$ 75.76
$ 75.86
$ 75.77 x 200
$ 75.78 x 200
$ 75.54 - $ 75.92
$ 59.55 - $ 76.80
5,319,658
na
118.34B
$ 0.56
$ 6.92
TBD
na
na ($ 0.02)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles
Cellectis Announces Completion Of AstraZen...
05/06/2024 08:11:35

As part of the Additional Investment, AstraZeneca subscribed today for 10,000,000 "class A" convertible preferred share...

Core News & Articles
ANGLE Inks Supplier Agreement with AstraZe...
05/03/2024 07:06:52

Under the terms of this agreement, worth £550,000 to ANGLE, the Company will develop a CTC-based AR assay. Assay development wi...

10-health-care-stocks-whale-activity-in-todays-session
10 Health Care Stocks Whale Activity In To...
05/02/2024 17:35:24

astrazenecas-high-level-results-from-interim-analysis-of-echo-phase-3-trial-of-calquence-combo-regime-showed-statistically-significant-clinically-meaningful-improvement-in-progression-free-survival-versus-soc-in-untreated-mantle-cell-lymphoma-patients
AstraZeneca's High-Level Results From Inte...
05/02/2024 09:10:21

Core News & Articles
Beyfortus Real-World Evidence Published In...
05/02/2024 07:12:26

New real-world evidence shows Beyfortus (nirsevimab) substantially reduced RSV lower respiratory tract disease and hospitaliz...

federal-trade-commission-targets-junk-patent-listings-for-diabetes-weight-loss-asthma-drugs-from-companies-like-novo-nordisk-astrazeneca
Federal Trade Commission Targets 'Junk Pat...
05/01/2024 20:11:33

The FTC intensifies efforts against pharmaceutical patent listings, disputing junk patents for diabetes, weight loss, asthma, a...

astrazeneca-disclosed-latest-research-across-key-respiratory-and-immune-mediated-diseases-at-ats-2024-showcasing-strength-of-its-broad-pipeline-and-portfolio
Astrazeneca Disclosed Latest Research Acro...
05/01/2024 11:27:24

astrazeneca-admits-its-covid-19-vaccine-may-cause-blood-clotting-side-effect-in-very-rare-case-but-causal-mechanism-unknown
AstraZeneca Admits Its COVID-19 Vaccine Ma...
04/29/2024 18:38:45

Discover the latest on AstraZeneca's Covid vaccine lawsuit. Allegations of serious side effects, including fatalities and b...

double-good-news-for-astrazenecas-breast-cancer-drugs
Double Good News For AstraZeneca's Breast ...
04/29/2024 13:25:58

Results from AstraZeneca's Enhertu trial vs. chemotherapy in HR-positive, HER2-low metastatic breast cancer.

on-sunday-telegraph-reported-that-astrazeneca-admits-for-first-time-in-court-documents-its-covid-vaccine-can-cause-rare-side-effect-the-company-is-being-sued-in-class-action-over-claims-its-vaccine-caused-death-and-serious-injury-in-dozens-of-cases
On Sunday Telegraph Reported That AstraZen...
04/29/2024 11:44:38

https://www.telegraph.co.uk/news/2024/04/28/astrazeneca-admits-covid-vaccine-causes-rare-side-effect/

Core News & Articles
Daiichi Sankyo And AstraZeneca's ENHERTU S...
04/29/2024 07:14:36

Daiichi Sankyo and AstraZeneca's ENHERTU also demonstrated a clinically meaningful progression-free survival improvement i...

will-earnings-cheer-continue-to-buoy-markets-apple-amazon-pfizer-coinbase-lead-flurry-of-q1-reports-this-week
Will Earnings Cheer Continue To Buoy Marke...
04/29/2024 05:51:21

With the earnings season now halfway through, the percentage of S&P 500 companies reporting positive earnings surprises and...

bmo-capital-maintains-outperform-on-astrazeneca-raises-price-target-to-82
BMO Capital Maintains Outperform on AstraZ...
04/26/2024 18:02:51

BMO Capital analyst Etzer Darout maintains AstraZeneca (NASDAQ:AZN) with a Outperform and raises the price target from $80 t...

top-4-health-care-stocks-that-may-plunge-this-month
Top 4 Health Care Stocks That May Plunge T...
04/26/2024 12:09:27

Core News & Articles
AstraZeneca, Through A Subsidiary, Will Ac...
04/25/2024 21:12:53

Fusion Pharmaceuticals Inc. (NASDAQ:FUSN), a clinical-stage oncology company focused on developing next-generation radioconjuca...

why-caterpillar-shares-are-trading-lower-by-around-7-here-are-other-stocks-moving-in-thursdays-mid-day-session
Why Caterpillar Shares Are Trading Lower B...
04/25/2024 17:57:17

stocks-drop-tech-tumbles-with-metas-weak-outlook-q1-stagflation-fears-gold-miners-advance-whats-driving-markets-thursday
Stocks Drop, Tech Tumbles With Meta's Weak...
04/25/2024 17:30:32

Wall Street suffers a double blow in Thursday’s session, as softer-than-expected revenue forecasts from Meta Platforms Inc. (NA...

sanofi-reports-strong-earnings-joins-kirby-sonic-automotive-union-pacific-and-other-big-stocks-moving-higher-on-thursday
Sanofi Reports Strong Earnings, Joins Kirb...
04/25/2024 14:15:30

astrazeneca-posts-bumper-earnings-on-strong-sales-from-cancer-drugs-sticks-to-annual-guidance
AstraZeneca Posts Bumper Earnings On Stron...
04/25/2024 13:03:20

AstraZeneca reports Q1 sales of $12.68 billion, up 17% Y/Y. Despite missing adjusted EPADS, oncology sees a 26% surge, driven b...

us-stocks-brace-for-negative-start-amid-tech-earnings-disappointments-caution-ahead-of-data-worst-of-this-two-week-decline-is-behind-us-says-analyst
US Stocks Brace For Negative Start Amid Te...
04/25/2024 10:17:18

The back-and-forth motion in the market continues, with the index futures pointing to a lower opening on Thursday. Meta Platfor...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION